Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 13, 2015European Journal of Hospital PharmacyOpen Access

Why shared-care arrangements for prescribing in attention deficit hyperactivity disorder may not be accepted

View Full Paper
Ask AI
Bookmark
Share

Authors

ICIM CarringtonJMJ McAloonNorthern Health and Social Care Trust

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Carrington et al. (2015) studied this question.

synapsesocial.com/papers/6a62f28e47366de40a28693fhttps://doi.org/10.1136/ejhpharm-2015-000743
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care2012 · 218 citations
  2. 2Interviews in Qualitative Research2011 · 2,219 citations
  3. 3A qualitative study of Australian GPs' attitudes and practices in the diagnosis and management of attention-deficit/hyperactivity disorder (ADHD)2003 · 46 citations
  4. 4Shared care arrangements for specialist drugs in the UK: the challenges facing GP adherence2010 · 12 citations